Company Filing History:
Years Active: 2013-2024
Title: The Innovations of Christophe Moinard
Introduction
Christophe Moinard is a notable inventor based in Bourg la Reine, France. He has made significant contributions to the field of health and nutrition, particularly through his innovative compositions aimed at treating diabetes and metabolic syndrome. With a total of four patents to his name, Moinard's work reflects a commitment to advancing medical science.
Latest Patents
Moinard's latest patents focus on compositions that comprise citrulline and leucine, along with their metabolites. These compositions are designed for use in the treatment of diabetes and metabolic syndrome. One of his patents details the use of citrulline and leucine, or metabolites such as hydroxyisocaproic acid (HICA) and beta-hydroxy-beta-methylbutyrate (HMB), in methods for treating pre-diabetes and metabolic syndrome. Another patent emphasizes the synergistic effects of these compounds in addressing hyperglycemia and diabetes.
Career Highlights
Throughout his career, Moinard has worked with prominent companies in the food and nutrition sector, including Nestec S.A. and Société des Produits Nestlé S.A. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in nutritional science.
Collaborations
Moinard has collaborated with esteemed colleagues such as Denis Breuille and Luc Cynober. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in health and nutrition.
Conclusion
Christophe Moinard's contributions to the field of health through his innovative patents demonstrate his dedication to improving treatment options for diabetes and metabolic syndrome. His work continues to influence the landscape of nutritional science and medical treatment.